ArticleMolecular biology reports2026
Isolation and partial 5'UTR-based molecular characterization of bovine enterovirus F from non-diarrheic cattle in Türkiye.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combined use of dill essential oil and tannic acid creates stage-specific, and time-dependent antiviral effect against bovine viral pathogens (BoHV-1, BVDV, BPIV-3, BRSV, and BEV).Veterinary research communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBovine enteroviruses (BEVs) are widely distributed among cattle worldwide and are commonly associated with subclinical infections, although their role in enteric, respiratory, and reproductive disorders remains incompletely understood. BEVs infect cattle as their natural host and are currently classified mainly within the species Enterovirus E and Enterovirus F. The advancement of virological research conducted as part of the elimination study may be affected by the concurrent circulation of enteric viruses, including BEV, in cattle populations. During a non-cytopathogenic BVDV elimination study, cytopathogenic agents unrelated to BVDV were incidentally detected and subjected to conventional virological and molecular identification. METHODS AND
resultsFor analysis, rectal and nasal swab samples were taken from 4 cattle showing mild respiratory symptoms on a farm, as well as blood samples from a total of 42 animals, including those that showed signs of contact. The cytopathogenic effect was detected in the Madin-Darby bovine kidney (MDBK) cell line by cultivation of fecal specimens. Two isolates were obtained and subjected to physicochemical characterization and determination of nucleic acid type. The fecal isolates were analyzed by RT-PCR using specific primers for possible key pathogens. The isolates showed resistance to chloroform and BrdU treatment, findings consistent with the characteristics of non-enveloped RNA viruses. Both isolates were positive in bovine enterovirus RT-PCR, and the molecular genetic analysis of the partial 5'UTR region of one of the isolates indicated that it belonged to the BEV-F clade. All 42 serum samples showed neutralizing activity at a dilution of ≥ 1:640 against the isolate used in the VNT.
conclusionThis study, based on partial 5'UTR sequence analysis, provides preliminary molecular evidence of a bovine enterovirus associated with EV-F in Türkiye. Given the limited number of studies conducted in Türkiye, these findings could lead to more comprehensive molecular characterization and epidemiological investigations. Although BEVs are not routinely prioritized in diagnostic screening panels for cattle, the incidental detection of cytopathogenic BEV isolates, together with the high seropositivity rate observed among in-contact animals, suggests that BEVs should be considered in virological investigations.
Indexed as
Identifiers
42627561What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.